The FDA still needs to officially authorize molnupiravir for people at high risk of severe COVID-19.
Jessica Rendall, CNET
Tue, 11/30/2021 - 4:35pm
The FDA still needs to officially authorize molnupiravir for people at high risk of severe COVID-19.